184 related articles for article (PubMed ID: 24879044)
1. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.
Gaines AR; Turner EL; Moorman PG; Freedland SJ; Keto CJ; McPhail ME; Grant DJ; Vidal AC; Hoyo C
Cancer Causes Control; 2014 Aug; 25(8):1029-35. PubMed ID: 24879044
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
3. Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
Jenkins KR; Oyekunle T; Howard LE; Wiggins EK; Freedland SJ; Allott EH
Cancer Causes Control; 2021 Apr; 32(4):337-346. PubMed ID: 33532986
[TBL] [Abstract][Full Text] [Related]
4. Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men.
Vidal AC; Oyekunle T; Howard LE; Shivappa N; De Hoedt A; Figueiredo JC; Taioli E; Fowke JH; Lin PH; Hebert JR; Freedland SJ
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):580-587. PubMed ID: 30980026
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
6. Is race a positive predictor of cancer on repeat prostate biopsy?
Yanke BV; Salzhauer EW; Colon I
J Urol; 2006 Sep; 176(3):1114-7. PubMed ID: 16890704
[TBL] [Abstract][Full Text] [Related]
7. Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.
Schulman AA; Howard LE; Tay KJ; Tsivian E; Sze C; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ; Polascik TJ
Cancer; 2017 Nov; 123(21):4122-4129. PubMed ID: 28662291
[TBL] [Abstract][Full Text] [Related]
8. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome is associated with aggressive prostate cancer regardless of race.
Guerrios-Rivera L; Howard LE; Wiggins EK; Hoyo C; Grant DJ; Erickson TR; Ithisuphalap J; Freedland AR; Vidal AC; Fowke JH; Freedland SJ
Cancer Causes Control; 2023 Mar; 34(3):213-221. PubMed ID: 36450931
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
Fowler JE; Bigler SA; Farabaugh PB
Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
[TBL] [Abstract][Full Text] [Related]
12. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
Yanke BV; Carver BS; Bianco FJ; Simoneaux WJ; Venable DD; Powell IJ; Eastham JA
BJU Int; 2006 Oct; 98(4):783-7. PubMed ID: 16978273
[TBL] [Abstract][Full Text] [Related]
13. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
[TBL] [Abstract][Full Text] [Related]
14. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
[TBL] [Abstract][Full Text] [Related]
15. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center.
Abern MR; Bassett MR; Tsivian M; Bañez LL; Polascik TJ; Ferrandino MN; Robertson CN; Freedland SJ; Moul JW
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):85-90. PubMed ID: 23069729
[TBL] [Abstract][Full Text] [Related]
16. Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer.
Hoge C; Verma S; Lama DJ; Bergelson I; Haj-Hamed M; Maynor S; Gaitonde K; Sidana A
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):567-572. PubMed ID: 32152436
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics in black and white men with prostate cancer in an equal access medical center.
Freedland SJ; Sutter ME; Naitoh J; Dorey F; Csathy GS; Aronson WJ
Urology; 2000 Mar; 55(3):387-90. PubMed ID: 10699616
[TBL] [Abstract][Full Text] [Related]
18. Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors.
Nettey OS; Walker AJ; Keeter MK; Singal A; Nugooru A; Martin IK; Ruden M; Gogana P; Dixon MA; Osuma T; Hollowell CMP; Sharifi R; Sekosan M; Yang X; Catalona WJ; Kajdacsy-Balla A; Macias V; Kittles RA; Murphy AB
Urol Oncol; 2018 Nov; 36(11):501.e1-501.e8. PubMed ID: 30236853
[TBL] [Abstract][Full Text] [Related]
19. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
Deka R; Parsons JK; Simpson DR; Riviere P; Nalawade V; Vitzthum LK; Kader AK; Kane CJ; Rock CS; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):581-588. PubMed ID: 32327702
[TBL] [Abstract][Full Text] [Related]
20. Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes.
Elliott CS; Shinghal R; Presti JC
J Urol; 2008 Oct; 180(4):1318-23; discussion 1323-4. PubMed ID: 18707710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]